Dec 2017 $2 M No. 4 $2 to $10 million 19
BioLogiQ, Inc.: Raise no. 4, Dec 2017 × Investors in this round 19 investors had bought by the notice of Apr 20, 2018: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $55,706
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bradford LaPray · Executive Officer, Director · Director and President Grantly Payne · Executive Officer, Director · Director and Secretary Ken Simpson · Executive Officer, Director · Director and Treasurer David Blue · Director Mark Weight · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round ViewTrade Securities, Inc. (CRD 46987) · Boca Raton, Florida Sold in AZ, CO, CT, FL, GA, IA, ID, KS, MN, TX, UT, VA, WI Signed by Bradford LaPray, President. Source: SEC Form D and 1 amendment, newest notice filed Apr 20, 2018. Read the notice at the SEC .
equity SEC Dec 2016 $4 M No. 3 $2 to $10 million 46
BioLogiQ, Inc.: Raise no. 3, Dec 2016 × Investors in this round 46 investors had bought by the notice of Feb 14, 2018: 46 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $520,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Bradford LaPray · Executive Officer, Director · Director and President Grantly Payne · Executive Officer, Director · Director and Secretary Ken Simpson · Executive Officer, Director · Director and Treasurer David Blue · Director Mark Weight · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round ViewTrade Securities, Inc. (CRD 46987) · Boca Raton, Florida Sold in AZ, CA, CO, FL, GA, ID, MN, ND, NJ, OK, TX, UT, VA, WI Signed by Bradford LaPray, President. Source: SEC Form D, newest notice filed Feb 14, 2018. Read the notice at the SEC .
equity, debt, options SEC Jan 2013 $5 M No. 2 $2 to $10 million 30
BioLogiQ, Inc.: Raise no. 2, Jan 2013 × Investors in this round 30 investors had bought by the notice of Feb 6, 2015: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $6 M offered; $1 M still to sell
Smallest investment taken $25,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bradford LaPray · Executive Officer, Director · Director and President Grantly Payne · Executive Officer, Director · Director and Secretary Ken Simpson · Executive Officer, Director · Director and Treasurer Brad Gardner · Director Ron Tanner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Bradford LaPray, President. Source: SEC Form D and 1 amendment, newest notice filed Feb 6, 2015. Read the notice at the SEC .
equity SEC Apr 2011 $3 M No. 1 $2 to $10 million 1
BioLogiQ, Inc.: Raise no. 1, Apr 2011 × Investors in this round 1 investor had bought by the notice of May 3, 2011: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bradford LaPray · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Common stock was issued in connection with the formation of the company in exchange for certain assets.”Signed by Bradford LaPray, President. Source: SEC Form D, newest notice filed May 3, 2011. Read the notice at the SEC .
equity SEC